These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8188458)

  • 21. [Use of captopril in diabetics].
    Jensovský J
    Vnitr Lek; 1995 Mar; 41(3):162-3. PubMed ID: 7762169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin converting enzyme inhibition in diabetic nephropathy. The Collaborative Study Group.
    Breyer JA; Hunsicker LG; Bain RP; Lewis EJ
    Kidney Int Suppl; 1994 Feb; 45():S156-60. PubMed ID: 8158886
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of captopril on diabetic proteinuria.
    N Engl J Med; 1986 Aug; 315(8):515-6. PubMed ID: 3526154
    [No Abstract]   [Full Text] [Related]  

  • 24. Diabetic nephropathy.
    Shlipak M
    Clin Evid; 2004 Dec; (12):814-33. PubMed ID: 15865682
    [No Abstract]   [Full Text] [Related]  

  • 25. [Economic evaluation of the contribution of captopril in the treatment of diabetic nephropathy:a cost-benefit approach].
    Le Pen C; Petitjean P; Lévy P; Hannedouche T
    Nephrologie; 1996; 17(6):321-6. PubMed ID: 8975150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.
    Lewis EJ; Hunsicker LG; Bain RP; Rohde RD
    N Engl J Med; 1993 Nov; 329(20):1456-62. PubMed ID: 8413456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of captopril and prazosin on renal function in diabetes.
    Omar MA; Motala AA; Seedat MA; Randeree HA
    S Afr Med J; 1993 May; 83(5):365. PubMed ID: 8211440
    [No Abstract]   [Full Text] [Related]  

  • 28. Arginase inhibition: a new treatment for preventing progression of established diabetic nephropathy.
    You H; Gao T; Cooper TK; Morris SM; Awad AS
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F447-55. PubMed ID: 26041444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Captopril--new additional applications].
    Shachar A; Shoenfeld Y
    Harefuah; 1990 Nov; 119(9):280-2. PubMed ID: 2258119
    [No Abstract]   [Full Text] [Related]  

  • 30. [Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy--a 6-month-long study].
    Hay U; Ludvik B; Gisinger C; Schernthaner G
    Schweiz Med Wochenschr; 1988 Feb; 118(5):165-9. PubMed ID: 3278375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of captopril in postponing nephropathy.
    Hjelm M
    BMJ; 1991 Aug; 303(6800):469. PubMed ID: 1781837
    [No Abstract]   [Full Text] [Related]  

  • 32. Longitudinal evaluation of renal function in non-insulin-dependent diabetic patients with early nephropathy: effects of angiotensin-converting enzyme inhibition.
    Vora JP; Leese GP; Peters JR; Owens DR
    J Diabetes Complications; 1996; 10(2):88-93. PubMed ID: 8777336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of antihypertensive (captopril) treatment on proteinuria in diabetic nephropathy.
    Holländer E
    Ther Hung; 1988; 36(4):191-5. PubMed ID: 3075819
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of antihypertensive (captopril) therapy on proteinuria in diabetic nephropathy].
    Holländer E
    Orv Hetil; 1987 Apr; 128(17):893-5. PubMed ID: 3295665
    [No Abstract]   [Full Text] [Related]  

  • 35. ACE inhibition and diabetic nephropathy.
    BMJ; 1991 Nov; 303(6814):1400-1. PubMed ID: 1810297
    [No Abstract]   [Full Text] [Related]  

  • 36. Captopril and hypertension in black diabetics.
    Burr AJ; Hay J
    BMJ; 1989 Aug; 299(6696):456-7. PubMed ID: 2507013
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on pyrazinoylguanidine. 5. Temporal effects over 24 weeks demonstrating attenuation of diabetic nephropathy in STZ-diabetic rats.
    Follansbee MH; Beyer KH; Griffith JW; Vesell ES
    Pharmacology; 1997 May; 54(5):241-55. PubMed ID: 9380770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amelioration of diabetic microalbuminuria and lipid peroxidation by captopril.
    Ha H; Kim KH
    Yonsei Med J; 1992 Sep; 33(3):217-23. PubMed ID: 1292245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of latent diabetic nephropathy with ACE inhibitor alacepril].
    Hashimoto T
    Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):549-56. PubMed ID: 1920934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic evaluation of ACE inhibitor treatment of nephropathy in patients with insulin-dependent diabetes mellitus in Italy.
    Garattini L; Brunetti M; Salvioni F; Barosi M
    Pharmacoeconomics; 1997 Jul; 12(1):67-75. PubMed ID: 10169388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.